Similar Items: Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
- Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2–naïve individuals
- CoV-UniBind: a unified antibody binding database for SARS-CoV-2
- Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection
- Detection of spike protein in term placentas of COVID-19 vaccinated and/or SARS-CoV-2 infected women
- Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivo
- Bronchial Hyperreactivity in the COVID-19 Era: The Impact of SARS-CoV-2 Infection and COVID-19 Vaccination in Patients with Respiratory Symptoms